Cargando…
Privileged fragment-based design, synthesis and in vitro antitumor activity of imatinib analogues
[Image: see text] Based on the privileged fragment-based drug design strategy, a series of imatinib analogues bearing the moiety of 3-(2-amino-2-oxoacetyl)-1H-indole were designed and synthesized, and the in vitro antitumor activity of these compounds was detected by MTT method using K562 (human mye...
Autores principales: | JIANG, Hongyu, WANG, Yuankun, JIANG, Maokai, YAO, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388080/ https://www.ncbi.nlm.nih.gov/pubmed/37528931 http://dx.doi.org/10.55730/1300-0527.3549 |
Ejemplares similares
-
Design, synthesis, and bioactivity evaluation of antitumor sorafenib analogues
por: Zhou, Shiyang, et al.
Publicado: (2018) -
Design, synthesis, and in vitro antitumor activity of 6-aryloxyl substituted quinazoline derivatives
por: FAN, Meixia, et al.
Publicado: (2022) -
In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates
por: Nesic de Freitas, Luca S. F., et al.
Publicado: (2023) -
Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors
por: Yang, Wei, et al.
Publicado: (2022) -
Design and synthesis of analogues of RA-VII—an antitumor bicyclic hexapeptide from Rubiae radix
por: Hitotsuyanagi, Yukio
Publicado: (2021)